纳指生物科技ETF(513290)
动态评分: 5.70分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2023-06-30 | HZNP | Horizon Therapeutics plc | 222.65 | 2.22% |
2023-06-30 | BMRN | 拜玛林制药 | 154.14 | 1.53% |
2023-06-30 | SNY | 赛诺菲 | 152.56 | 1.52% |
2023-06-30 | INCY | 因塞特医疗 | 131.57 | 1.31% |
2023-06-30 | RPRX | Royalty Pharma plc-A | 130.47 | 1.3% |
2023-06-30 | VTRS | Viatris Inc | 113.33 | 1.13% |
2023-06-30 | ARGX | argenx SE ADR | 110.11 | 1.1% |
2023-06-30 | SRPT | Sarepta Therapeutics Inc | 101.04 | 1.01% |
2023-06-30 | APLS | Apellis Pharmaceuticals Inc | 100.45 | 1% |
2023-06-30 | UTHR | 联合治疗 | 98.1 | 0.98% |
2023-06-30 | BNTX | BioNTech SE ADR | 95.61 | 0.95% |
2023-06-30 | NBIX | 神经分泌生物科学 | 87.15 | 0.87% |
2023-06-30 | KRTX | Karuna Therapeutics Inc | 76.78 | 0.76% |
2023-06-30 | JAZZ | 爵士制药 | 75.16 | 0.75% |
2023-06-30 | ROIV | Roivant Sciences Ltd | 72.41 | 0.72% |
2023-06-30 | BGNE | 百济神州 | 69.83 | 0.69% |
2023-06-30 | MEDP | Medpace Holdings Inc | 69.24 | 0.69% |
2023-06-30 | EXEL | 伊克力西斯 | 58.93 | 0.59% |
2023-06-30 | ITCI | Intra-Cellular Therapies Inc | 57.56 | 0.57% |
2023-06-30 | IONS | Ionis Pharmaceuticals Inc | 55.59 | 0.55% |
公告&资料
